Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

HIV Positive Clinical Trial

— MMC-1  

Official title:

Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01536899
• Other study ID #: MMC-1
• Secondary ID: R01DA032678
• Status: Completed
• First received: February 16, 2012
• Last updated: April 3, 2018
• Start date: February 2012
• Est. completion date: June 2017

Study information

• Verified date: April 2018
• Source: Wayne State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients.

Several alternative hypotheses will be evaluated in the proposed project:

1. healthier patients may self-select marijuana use;

2. marijuana use may be associated with consequences that create barriers to seeking healthcare;

3. marijuana use may have medicinal value that reduces the need for such care.

Description:

The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year.

The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time.

We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 119
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Participants will be patients in the HIV clinic.

• Participants will have HIV.

• Participants will sign a single consent form.

• Participants will be marijuana users.

Exclusion Criteria:

• Participants who test negative for marijuana will be excluded.

• Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.

Related Conditions & MeSH terms

• HIV Positive
• HIV Seropositivity
• Marijuana Abuse
• Marijuana Smoking

Locations

Country	Name	City	State
United States	Wayne State University (HIV clinic, Tolan Park Medical Buiding)	Detroit	Michigan

Sponsors (2)

Lead Sponsor	Collaborator
Wayne State University	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States,